Rising MRSA blamed on 'production-line' medicine

Production-line medicine is to blame for rising rates of the deadly MRSA superbug infection in the North’s acute hospitals, according to research published today.

Rising MRSA blamed on 'production-line' medicine

Production-line medicine is to blame for rising rates of the deadly MRSA superbug infection in the North’s acute hospitals, according to research published today.

Pressure on managers and doctors to meet targets on the numbers of patients treated was one of the causes.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited